Resultado de búsqueda
Hace 10 horas · This work is supported by a US Cystic Fibrosis Foundation grant, Cure4CF Impact Grant, the Bellberry New Investigator Award, and the Japanese Respiratory Society ECR Development Award. Cystic Fibrosis Australia awarded PhD student Danni Li the CFWA Post Graduate Top Up Scholarship 2024.
Hace 10 horas · RCT2100, a cystic fibrosis mRNA drug developed by ReCode Therapeutics, is one of multiple mRNA drugs currently in human trials for this application. Here, an inhaled form of mRNA is introduced to the lung cells to help them produce healthy CFTR proteins, with the aim of reducing the build-up of thick mucus and alleviating the symptoms experienced by cystic fibrosis patients.
Hace 10 horas · Given the various clinical manifestations that characterize Coronavirus Disease 2019 (COVID-19), the scientific community is constantly searching for biomarkers with prognostic value. Surfactant proteins A (SP-A) and D (SP-D) are collectins that play a crucial role in ensuring proper alveolar function and an alteration of their serum levels was reported in several pulmonary diseases ...
Hace 10 horas · Inflammatory bowel disease, intestinal parasites, irritable bowel syndrome, cystic fibrosis: Treatment: ... According to the European Society for the Study of Celiac Disease (ESsCD), coeliac disease can be associated with hyposplenism or functional asplenia, which could result in impaired immunity to encapsulated bacteria, ...
Hace 1 día · BiomX is working closely with the CF Foundation to design the Phase 2b study for cystic fibrosis. ... in April we presented positive safety and efficacy results on Part 2 of the Phase Ib/2a trial of BX004 at the European Society of Clinical Microbiology and Infectious Disease, or ESCMID Global Congress.
Hace 10 horas · Please go ahead, Avi. Avi Gabay. Thank you, and welcome to the BiomX first-quarter 2024 financial results and corporate update conference call. The press release became available just after 6:30 ...
Hace 10 horas · Inquiry Launched into DWP’s Treatment of Ill and Disabled Benefit Claimants. The Department for Work and Pensions (DWP) is set to face an inquiry into its treatment of ill and disabled individuals receiving benefits. This move follows growing concerns and numerous reports highlighting the struggles faced by some of the most vulnerable members of society under the current welfare system.
